6533b7d0fe1ef96bd125af53
RESEARCH PRODUCT
Hematopoietic stem cell quiescence and function are controlled by the CYLD–TRAF2–p38MAPK pathway
Yilang TangMassimo SainiAri WaismanMelania TesioElizabeth MacintyreAndreas TrumppLisa Von PaleskeKatja MüdderManolis Pasparakissubject
TRAF2Tumor suppressor geneMAP Kinase Signaling SystemImmunologyRegulatorBiologyp38 Mitogen-Activated Protein KinasesArticleMicemedicineAnimalsImmunology and AllergyMice KnockoutRegulation of gene expressionNF-kappa BHematopoietic stem cellCell BiologyHematopoietic Stem CellsTNF Receptor-Associated Factor 2PhenotypeDeubiquitinating Enzyme CYLDCell biologyCysteine EndopeptidasesHaematopoiesismedicine.anatomical_structureGene Expression RegulationMutationStem celldescription
Tesio at al. identify a novel pathway controlled by the tumor suppressor and deubiquitinase cylindromatosis (CYLD), which is involved in the regulation of hematopoietic stem cell quiescence and repopulation potential.
year | journal | country | edition | language |
---|---|---|---|---|
2015-04-13 | Journal of Experimental Medicine |